The decrease in paclitaxel CL noticed during the existence of zosuquidar brought about a increase in the time which the plasma paclitaxel focus stays previously mentioned 0.1 mol L−one, which is known to be a marker of both toxicity (neutropenia) and efficacy [1]. Even though the result of zosuquidar within https://damiend443sdo6.mysticwiki.com/user